L

Luye Pharma USA

U.S. clinical-regulatory hub for therapies.

Psychiatric Account Manager

Full-TimeUpdated
No salary listed
Senior
Bachelor's
New York, NY, USA
In PersonTerritory includes all of Long Island, New York; candidates must live near the territory boundaries.
Sales & Account ManagementAccount Management

About the job

Requirements
  • A bachelor's degree is required; Life Sciences is preferred.
  • At least 5 years of direct selling experience to healthcare professionals in the Pharmaceutical, Biotech, or Healthcare industry is required.
  • Psychiatric experience is required.
  • A working knowledge of the Schizophrenia field is strongly preferred.
  • CMHC account management and/or Hospital/Institutional experience is strongly preferred.
  • Established relationships in the geography are strongly preferred.
  • Knowledge of the formulary approval process and driving formulary approvals is preferred.
  • Must live near the territory boundaries.
  • A proven track record of success in a high-science competitive selling environment is required.
  • Ability to identify key decision makers, develop positive relationships, and demonstrate strong customer dedication is required.
  • A proven track record of exceeding results is required.
  • Strong communication, business analytics, and account management skills are required.
  • Ability to work independently or in a team environment is required.
  • A valid driver's license and safe driving record are required.
Responsibilities
  • Build relationships with recognized experts and prioritized stakeholders in the therapeutic area, Community Mental Health Clinics, hospital/institutional systems, and integrated delivery networks.
  • Develop and drive relationships with target institutions and community accounts, including establishing and maintaining positive relationships with key influencers and decision makers.
  • Collaborate in a complex, matrixed selling environment with cross-functional partners, including Account Partners, Market Access, Medical, Marketing, and Operations colleagues.
  • Develop a collaborative partnership with field-based colleagues to provide appropriate cross-functional support for customers within a defined geography and develop and execute pull-through strategies.
  • Identify key influencers and meet designated customer interaction expectations, focusing on top target customers.
  • Use data tools, insights, and other informational sources to determine strategies and tactics for business decision-making.
  • Use account-based selling skills, including group presentations, and build relationships in institutions aligned with customer segmentation.
  • Plan and organize activities to ensure regular and consistent territory coverage according to a plan of action.
  • Deliver clinical, brand-specific product presentations to physicians and other appropriate health care professionals.
  • Develop product and competitor knowledge and understanding of local and regional market trends.
  • Manage the territory budget to support sales and marketing activities.
  • Complete administrative tasks in a timely manner.
  • Execute the company brand strategy and tactics within the assigned geographic area.
  • Participate in training and development programs.
  • Adhere to corporate and industry policies and procedures.
Desired Qualifications
  • Life Sciences degree field.
  • Working knowledge of the Schizophrenia field.
  • CMHC account management and/or Hospital/Institutional experience.
  • Established relationships in the geography.
  • Knowledge of the formulary approval process and driving formulary approvals.

About the company

Luye Pharma USA develops and commercializes medicines in CNS, oncology, and cardiovascular diseases in the U.S., using advanced drug-delivery technologies like long-acting injectables, liposomes, and transdermal systems. Its products include Rykindo (risperidone long-acting injectable) approved by the FDA in 2023 and ERZOFRI (paliperidone palmitate) launched in 2025. The company sells through direct and B-to-B channels across 80+ countries and expands its pipeline through strategic acquisitions. Its goal is to build a global portfolio of in-house developed CNS, oncology, and cardiovascular therapies by advancing R&D, securing regulatory approvals, and scaling commercial operations.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A